Irreversible menin inhibitor, BMF-219, inhibits the growth of KRAS-mutated solid tumors (Abstract #1202)
Apr 12, 2022 from 9:00 AM to 12:30 PM CDT
Session Category: Experimental and Molecular Therapeutics
Session Title: Signaling Pathway Inhibitors
Location: New Orleans Convention Center, Exhibit Halls D-H, Poster Section 25
Poster Board Number: 8
Permanent Abstract Number: 2665
Session Title: Signaling Pathway Inhibitors
Location: New Orleans Convention Center, Exhibit Halls D-H, Poster Section 25
Poster Board Number: 8
Permanent Abstract Number: 2665